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Abstract We have previously reported that stimulation of
alpha-1 adrenoceptors by noradrenaline (NA) injected into
the lateral septal area (LSA) of anaesthetized rats causes
pressor and bradycardic responses that are mediated by
acute vasopressin release into the circulation through
activation of the paraventricular nucleus (PVN). Although
the PVN is the final structure of this pathway, the LSA has
no direct connections with the PVN, suggesting that other
structures may connect these areas. To address this issue,
the present study employed c-Fos immunohistochemistry
to investigate changes caused by NA microinjection into
the LSA in neuronal activation in brain structures related to
systemic vasopressin release. NA microinjected in the LSA
caused pressor and bradycardic responses, which were
blocked by intraseptal administration of a-1 adrenoceptor
antagonist (WB4101, 10 nmol/200 nL) or systemic V-1
receptor antagonist (dTyr(CH2)5(Me)AVP, 50 lg/kg). NA
also increased c-Fos immunoreactivity in the prelimbic
cortex (PL), infralimbic cortex (IL), dorsomedial periaqu-
eductal gray (dmPAG), bed nucleus of the stria terminalis
(BNST), PVN, and medial amygdala (MeA). No differ-
ences in the diagonal band of Broca, cingulate cortex, and
dorsolateral periaqueductal gray (dlPAG) were found.
Systemic administration of the vasopressin receptor
antagonist dTyr AVP (CH2)5(Me) did not change the
increase in c-Fos expression induced by intra-septal NA.
This latter effect, however, was prevented by local injec-
tion of the alpha-1 adrenoceptor antagonist WB4101.
These results suggest that areas such as the PL, IL,
dmPAG, BNST, MeA, and PVN could be part of a circuit
responsible for vasopressin release after activation of
alpha-1 adrenoceptors in the LSA.
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Introduction
Arterial blood pressure is regulated by a short and long-
term feedback control system which relies on autonomic
nerves and circulating hormones as their effector mecha-
nisms. The central regulation of the cardiovascular system
involves bulbar centers, such as the nucleus of the solitary
tract (NTS), the rostral ventrolateral medulla (RVLM), the
caudal ventrolateral medulla (CVLM), and nucleus
ambiguous (Spyer 1994). Supramedullary structures, such
as the periaqueductal gray (PAG), the cuneiform nucleus,
the hypothalamus, the central nucleus of amygdala, specific
regions of the cerebral cortex, and the lateral septal area
(LSA) also participate in the control of the cardiovascular
system, usually reflecting behavior changes (Dampney
1994; Loewy 1991; Loewy and McKellar 1980). In par-
ticular, the LSA is a limbic structure well described to be
involved in the modulation of autonomic and behavioral
processes (Covian 1966; Reis et al. 2010; Scopinho et al.
2006), and chemical stimulation of this structure usually
evokes cardiovascular responses (Gelsema and Calaresu
1987; Pirola et al. 1987).
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We have previously reported that alpha-1 adrenoceptors
stimulation by microinjection of noradrenaline (NA) into
the LSA of anaesthetized rats causes pressor and brady-
cardiac responses that are mediated by acute vasopressin
release into the circulation (Scopinho et al. 2006), sug-
gesting that noradrenergic mechanisms in this area could
regulate the cardiovascular system. The responses to NA
were blocked by the nonspecific synaptic blocker cobalt
chloride (CoCl2) or the selective non-N-methyl-D-aspartate
(NMDA) antagonist NBQX microinjected into the para-
ventricular nucleus (PVN), suggesting that this region is the
final structure in the pressor pathway activated by NA
microinjection into the LSA (Scopinho et al. 2008). How-
ever, there is no evidence of direct connections between
these areas (Tavares et al. 2005), suggesting the involve-
ment of other intermediate structures.
The LSA connects with several key regions in the
control of motivational and autonomic responses, such as
the hippocampus, lateral and medial hypothalamus, peri-
aqueductal gray (PAG), amygdala, bed nucleus of stria
terminalis (BNST), medial prefrontal cortex (MPFC),
diagonal band of Broca (DBB), and the medial septal area
(Risold and Swanson 1997; Sheehan et al. 2004). Previous
studies by our group showed that stimulation of BNST,
MPFC, DBB, PAG, and medial amygdaloid nucleus
(MeA) directly or indirectly activates the hypothalamic
nuclei responsible for the release of vasopressin, causing
pressor and bradycardic responses in rats (Crestani et al.
2007; Fernandes et al. 2003; Fortaleza et al. 2011; Pelosi
and Correa 2005; Tavares and de Aguiar Correa 2003).
These responses are similar to those evoked by NA in the
LSA, suggesting the involvement of these areas in central
mediated release of vasopressin into the systemic
circulation.
To further investigate this issue, the present study uses
c-Fos immunohistochemistry to indentify if these areas are
activated after local injection of NA in the LSA. Our
hypothesis is that they are part of a brain circuit engaged
by NA in the LSA and responsible for controlling the
central-mediated release of vasopressin in the systemic
circulation.
Materials and Methods
Animal Preparation
Male Wistar rats weighing 220–270 g were used. Animals
were kept in the Animal Care Unit of the Department of
Pharmacology of the School of Medicine of Ribeira˜o
Preto, University of Sa˜o Paulo. Rats were housed indi-
vidually in plastic cages in a 23–25 C temperature-con-
trolled room, with free access to water and commercial
food. The Institution’s Animal Ethics Committee
approved the housing conditions and experimental proto-
cols (057/2009). Rats were anesthetized with tribromo-
ethanol, 250 mg/kg i.p. After local anesthesia with 2%
lidocaine, the skull was surgically exposed and stainless-
steel guide cannulae (0.6-mm o.d.) were implanted 1 mm
above the injection sites using a stereotaxic apparatus
(Stoelting, Wood Dale, IL, USA). Stereotaxic coordinates
for implantation of cannulae were selected from the rat
brain atlas (Paxinos and Watson 1997). The coordinates
used were AP = ?8.3 mm, L = ?0.5 mm, and V = -
4.1 mm for cannulae implantation in the LSA. All can-
nulae were implanted unilaterally. Cannulae were fixed to
the skull with dental cement (Simplex, DFL, Rio de
Janeiro, Brazil) and one metal screw. A tight-fitting tro-
cater was kept inside the guide cannulae to prevent
occlusion. Animals were treated with an antibiotic com-
bination of penicillin and streptomycin (Pentabio´tico, Fort
Dodge Ltda, Brazil; 0.1 ml/kg), and flunixin meglumine
(2.5 mg/kg s.c.) was used as a postoperative analgesic and
anti-inflammatory agent. Two days later, the animals were
anesthetized with tribromoethanol and a polyethylene
catheter was implanted into the femoral artery for blood
pressure and heart rate recording. The arterial catheter
consisted of a segment of PE-10 tubing (4–5 cm) heat-
bonded to a longer segment of PE-50 tubing (12 cm). The
catheter was filled with 0.3 % heparin (stock solution
5,000 U/ml) in sterile saline (150 mM NaCl). The PE-10
segment was introduced into the femoral artery until the
tip reached the aorta. The catheter was secured in position
with thread, and the PE-50 segment was passed under the
skin to be extruded on the dorsum of the animals. Flunixin
meglumine (2.5 mg/kg s.c.) was used as a postoperative
analgesic and anti-inflammatory treatment. After surgery,
the animals were allowed to recover for 24 h.
Measurement of Cardiovascular Responses
The animals were kept in individual cages in the Animal
Care Unit, which were transported to the experimental
room. Animals were allowed 15 min to adapt to the con-
ditions of the experimental room, such as sound and illu-
mination, before starting blood pressure and heart rate
recording. The experimental room was acoustically iso-
lated and had constant background noise caused by an air
exhauster. At last another 15-min period was allowed
before the experiments were initiated, and care was taken
to start the injection whenever a stable blood pressure and,
especially, a stable heart rate were observed. The injection
needle was slowly introduced into the guide cannulae
without touching or restraining the animals. Pulsatile
arterial pressure (PAP) of freely moving animals was
recorded using an HP-7754A preamplifier (Hewlett
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Packard, Palo Alto, CA, USA) and an acquisition board
(MP100A; Biopac Systems Inc., Goleta, CA, USA) con-
nected to a computer.
Drugs
Noradrenaline-HCl (21 nmol/200 nL; Sigma, St Louis,
MO, USA) and WB4101 (10 nml/200 nL; a1-adrenergic
antagonist; TOCRIS, Westwoods Business Park Ellisville,
MO, USA) were dissolved in sterile artificial cerebrospinal
fluid (aCSF composition: NaCl 100 mM; Na3PO4 2 mM;
KCl 2.5 mM; MgCl2 1 mM; NaHCO3 27 mM; CaCl2
2.5 mM; pH 7.4). tribromoethanol (Sigma, St Louis, MO,
USA), urethane (Sigma, St Louis, MO, USA) and dTyr
(CH2)5(Me) AVP (50 mg/Kg; V1-vasopressin receptor
antagonist, Peninsula, Belmont, CA, USA) were dissolved
in saline (0.9 %). flunixine meglumine (Banamine,
Schering Plough, Brazil) and poly-antibiotic preparation of
streptomycins and penicillins (Pentabiotico, Fort Dodge,
Brazil) were used as provided. All doses of the drugs used
were based in those employed in a previous study by
Scopinho et al. 2006.
Histological Procedure
At the end of the experiments, the rats were anesthetized
with urethane (1.25 g/kg, i.p.) and 200 nL of filtered 1 %
Evan’s blue dye was injected into the brain as a marker of
the injection site. The chest was surgically opened, the
descending aorta occluded, the right atrium severed, and
the brain perfused with 10 % formalin through the left
ventricle. The brains were post-fixed for 24 h at 4 C, and
40-lm sections were cut with a cryostat (CM 1900; Leica,
Wetzlar, Germany). Brain sections were stained with 0.5 %
cresyl violet for light microscopy analysis. The injection
sites were verified in serial sections.
Immunohistochemistry
Two hours after the experimental procedures the animals
were anaesthetized with urethane and perfused transcar-
dially with saline followed by 4 % paraformaldehyde (PFA)
in 0.1 M phosphate buffer (PB, pH 7.4). Brains were
removed and post-fixed over 2 h in PFA and stored for at
least 30 h in 30 % sucrose for cryoprotection. Coronal sec-
tions (40 lm) were obtained in duplicate in a cryostat. After
this, the sections were processed for c-Fos immunohisto-
chemistry as previously described (Aguiar and Guimaraes
2009; Beijamini and Guimaraes 2006). Briefly, tissue sec-
tions were washed and incubated overnight at room tem-
perature with rabbit IgG (1/1,000 into TBS 0.01 M, sc 52,
Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA),
which was raised against an amino-acid sequence of the
N-terminal region of the peptide an specifically recognizes
c-Fos. After incubation in the primary antiserum, the tissue
sections were washed in TBS and sequentially incubated
with a biotinilated goat anti-rabbit IgG (1:1,000 into TBS
0.01 M). Sections were then processed by the avidin–biotin
immunoperoxidase method (Vectastain ABC kit, Vector
Lab, Burlingame, CA, USA). c-Fos immunoreactivity (FLI)
was revealed by the addition of the chromogen diam-
inobenzidin (Sigma, into TBS, H2O2 0.02 % and niquel
sulfate 1 %) and visualized as a black reaction product inside
the neuronal nuclei.
The identification method of stained cells was similar to
that described in previous works (Aguiar and Guimaraes
2009; Lino-de-Oliveira et al. 2001). The number of FLI
was counted with the help of a computerized image anal-
ysis system (Image-Pro Plus, Media Cybernetics, Silver
Spring, MD, USA). The system was calibrated to ignore
background staining. Darker objects with areas between 10
and 80 lm2 were identified as Fos-positive neurons. An
observer blind to group assignment performed the analysis.
For each group one section from each animal was evalu-
ated. All stained cells in the whole area of each brain
region of interested were recorded. For bilateral structures,
the mean value between of the structure was calculated.
The areas of the analyzed regions were calculated and the
results expressed as the number of positive cells/0.1 mm2.
Neuroanatomical sites were identified with the help of the
Paxinos and Watson’s atlas (Paxinos and Watson 1997).
The anterior–posterior (AP) localization from bregma of
the analyzed regions were as follows: cingulate cortex 1
(Cg 1, AP: 2.7 mm), infralimbic cortex (IL, AP: 2.7 mm),
prelimbic cortex (PL, AP: 2.7 mm), diagonal band of
Broca (DBB, AP: 0.84 mm), bed nucleus of stria terminalis
(BNST, AP: -0.2 mm), paraventricular hypothalamic
nucleus (PVN, AP: -1.8 mm), medial amygdaloid nucleus
(MeA, AP: -2.76 mm), dorsomedial periaqueductal gray
(dmPAG, AP: -6.6 mm), and dorsolateral periaqueductal
gray (dlPAG, AP: -6.6 mm).
Statistical Analysis
Two-way ANOVA (treatment vs. time) followed by Bon-
ferroni’s post hoc test was used to compare effects of the
treatments on cardiovascular MAP and HR changes
observed after microinjection of NA into the LSA. Basal
values of MAP and HR were compared by paired Student’s
t test. The immunohistochemistry data were analyzed by
One-way ANOVA followed by Newman and Keuls post
hoc test. The significance level was set at P \ 0.05 in
GraphPad Prism software.
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Results
Effect of Intra-LSA Pretreatment with aCSF
or WB4101 on Cardiovascular Responses
to the Microinjection of NA into the LSA
of Unanesthetized Rats
aCSF
Pretreatment with aCSF (n = 5) in the LSA did not affect
neither the pressor (26.8 ± 1.9 vs. 26 ± 1.8 mm Hg,
t = 2.1, P [ 0.05) nor the bradycardiac (45.4 ± 8.3 vs.
43 ± 1.9 bpm, t = 0.3, P [ 0.05) responses to NA
microinjected into the LSA.
WB4101
Intraseptal injection of WB4101 (10 nmol/200 nL) did not
affect baseline MAP (96.9 ± 2.4 vs. 94.5 ± 0.7 mmHg,
t = 0.8, P [ 0.05, n = 5) or HR (350 ± 3.5 vs. 359.1 ±
4.1 bpm, t = 2.1, P [ 0.05, n = 5). However, two-way
ANOVA indicated significant effects of WB4101 on NA
cardiovascular effects (MAP: F1,88 = 437.3, P \ 0.0001;
and HR: F1,88 = 111, P \ 0.0001); a significant effect over
time (MAP: F10,88 = 21.60, P \ 0.0001; and HR: F10,88
= 10.4, P \ 0.0001) and interaction between treatment and
time (MAP: F10,88 = 30.17, P \ 0.0001; and HR: F10,88
= 10.9, P \ 0.0001; Fig. 1 left)
Diagrammatic representation of the injection sites in the
LSA are represented in the Fig. 2.
Effect of Systemic Pretreatment with ACSF
or dTyr(CH2)5(Me)AVP on Cardiovascular Responses
to the Microinjection of NA into the LSA
of Unanesthetized Rats
aCSF
I.v. pretreatment with aCSF (n = 5) did not affect neither
the pressor (27.2 ± 1.2 vs. 25.6 ± 2 mm Hg, t = 0.9,
P [ 0.05) nor the bradycardiac (43.8 ± 5 vs. 43.6 ±
5.1 bpm, t = 0.04, P [ 0.05) responses to NA microin-
jected into the LSA.
dTyr(CH2)5(Me)AVP
Pretreatment with dTyr(CH2)5(Me)AVP, i.v., (50 lg/kg)
did not affect baseline MAP (100.4 ± 3.9 vs. 100.7 ±
3.2 mmHg, t = 0.7, P [ 0.05, n = 5) or baseline HR
(345.9 ± 2.7vs. 349.1 ± 3.3 bpm, t = 1.3, P [ 0.05,
n = 5). However, two-way ANOVA indicated significant
effects of dTyr(CH 2) 5 (Me)AVP on NA cardiovascular
effects (MAP: F1,88 = 283.6, P \ 0.0001; and HR: F1,88
= 95.62, P \ 0.0001); a significant effect over time (MAP:
F10,88 = 14.1, P \ 0.0001; and HR: F10,88 = 9.5, P \
0.0001) and interaction between treatment and time (MAP:
F10,88 = 18.9, P \ 0.0001; and HR: F10,88 = 7.6, P \
0.0001; Fig. 1 right).
c-Fos Immunoreactivity (FLI) Following NA or aCSF
Microinjected into the LSA of Rats Before and After
Local Pretreatment with WB4101
or dTyr(CH2)5(Me)AVP Injected Systemically
FLI was detected in several areas after NA microinjection
into the LSA (Table 1). Intra-LSA NA induced a signifi-
cant increase in FLI in the PVN (F(5,29) = 104.3, P \
0.0001), BNST (F(5,29) = 1644, P \ 0.0001), dmPAG
(F(5,29) = 733.9, P \ 0.0001), PL (F(5,29) = 3718, P \
0.0001), IL (F(5,29) = 3236, P \ 0.0001) and MeA
(F(5,29) = 1210, P \ 0.0001). In the DBB (F(5,29) = 0.2,
P [ 0.05), dlPAG (F(5,29) = 1.1, P [ 0.05) and Cg1
(F(5,29) = 1.0, P [ 0.05) there were no differences
between animals that received NA or vehicle (Fig. 3).
Intra-LSA microinjection of WB4101 (10 nmol/200 nL)
significantly attenuated the increased in FLI induced by
NA intra-LSA in PVN (Newman–Keuls P \ 0.001), BNST
(Newman–Keuls P \ 0.001), dmPAG (Newman–Keuls
P \ 0.001), PL (Newman–Keuls P \ 0.001), IL (New-
man–Keuls P \ 0.001) and MeA (Newman–Keuls P \
0.001), when compared with the group that received aCSF
(Fig. 3).
dTyr (CH2)5(Me) AVP (50 microg/kg) i.v. treatment
did not attenuate the increase in FLI induced by intra-LSA
NA in the PVN (Newman–Keuls P [ 0.05), BNST
(Newman–Keuls P [ 0.05), dmPAG (Newman–Keuls
P [ 0.05), PL (Newman–Keuls P [ 0.05), IL (Newman–
Keuls P [ 0.05) and MeA (Newman–Keuls P [ 0.05)
(Fig. 3).
Photomicrographs showing c-Fos immunohistochemis-
try (black arrow) in some structures related above are
present in Fig. 4.
Discussion
In the present study, we showed that NA microinjected into
the LSA, in addition to evoke pressor and bradycardic
responses dependent on vasopressin, is also able to increase
c-Fos expression in brain regions that can facilitate the
release of this hormone.
c-Fos expression increased in the bed nucleus of stria
terminalis (BNST), dorsomedial periaqueductal gray
(dmPAG), prelimbic (PL) and infralimbic (IL) cortices,
medial amygdaloid nucleus (MeA), and paraventricular
nucleus of hypothalamus (PVN), suggesting that these
1150 Cell Mol Neurobiol (2012) 32:1147–1157
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Fig. 1 Left-time course of the effect of NA (21 nmol/200 nL)
microinjected into the LSA on MAP and HR before and after local
pretreatment with WB4101 (10 nmol/200 nL, n = 5). Right-time
course of the effect of NA (21 nmol/200 nL) microinjected into the
LSA on MAP and HR before and after i.v. pretreatment with
dTyr(CH2)5(Me)AVP (d-Tyr AVP, 50 l g/kg, n = 5). NA injections
were made at time 2. Points represent the mean and bars the SEM;
two-way ANOVA followed by Bonferroni’s post hoc test
Fig. 2 Diagrammatic
representation indicating the
microinjection sites of NA
(black circles), aCSF (black
squares), or WB4101 (white
squares) in the LSA.
Coordinates based on the atlas
of Paxinos and Watson (1997).
I.A. interaural coordinate; LSA
lateral septal area; CC corpo
calosum; and LV lateral
ventricle
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Table 1 Fos-like immunoreactivity in brain regions of rats after
microinjections into the LSA of WB4101 (WB, 10 nml/200 nL) or
systemic injection of dTyr (CH2)5(Me) AVP (Dtyr, 50 mg/Kg)
followed by intra-LSA microinjection of aCSF or Noradrenaline (NA,
21 nmol/200 nL), n = 5 per group
Structure aCSF NA Dtyr ? aCSF Dtyr ? NA WB ? aCSF WB ? NA
PVN 5.98 ± 1.45 91.54 ± 6.72* 2.42 ± 0.71# 85.50 ± 7.20* 3.59 ± 1.43# 9.54 ± 2.16#
BNST 1.45 ± 0.47 108.3 ± 2.45* 2.33 ± 0.73# 111.0 ± 1.65* 3.43 ± 0.93# 2.99 ± 0.87#
dmPAG 5.78 ± 0.90 110.7 ± 2.60* 3.87 ± 1.36# 111.9 ± 2.14* 4.47 ± 1.55# 6.01 ± 2.84#
PL 1.58 ± 0.44 107.0 ± 1.54* 2.87 ± 0.62# 105.4 ± 0.84* 1.74 ± 0.81# 1.72 ± 0.57#
IL 1.40 ± 0.56 107.6 ± 1.61* 2.43 ± 0.61# 108.3 ± 1.32* 2.25 ± 0.53# 1.59 ± 0.45#
MeA 1.71 ± 0.63 106.6 ± 1.82* 3.79 ± 1.03# 108.4 ± 2.87* 2.14 ± 0.79# 2.18 ± 0.95#
DBB 5.04 ± 0.75 4.69 ± 1.43 4.13 ± 0.87 4.77 ± 1.23 6.07 ± 2.40 4.66 ± 1.18
dlPAG 4.69 ± 0.95 3.57 ± 0.90 4.11 ± 1.21 3.46 ± 0.89 5.52 ± 1.34 6.83 ± 1.69
Cg1 5.34 ± 1.56 4.08 ± 1.15 4.30 ± 1.12 5.11 ± 0.64 8.60 ± 2.81 6.29 ± 1.66
Data are expressed as means ± SEM, n = 5/group. PVN paraventricular nucleus of hypothalamus, BNST bed nucleus of stria terminalis, dmPAG
dorsomedial periaqueductal gray, PL and IL prelimbic and infralimbic prefrontal cortex, MeA medial amygdaloid nucleus, DBB diagonal band of
Broca, dlPAG dorsolateral periaqueductal gray, and Cg1 cingulate cortex area 1
* Different from vehicle-treated group (aCSF) group, P \ 0.0001
# Different from NA-treated (NA) group, P \ 0.0001
Fig. 3 Effects of microinjection of 200 nL of aCSF or 21 nmol of
noradrenaline (NA) into the LSA before and after i.v. pretreatment
with dTyr(CH2)5(Me)AVP (d-Tyr AVP, 50 lg/kg) or LSA local
pretreatment with 10 nmol of WB4101 on the number of c-Fos
positive cells in rats (n = 5 per group). Bars represent the mean
(±SEM). *P \ 0.05 compared to vehicle-treated group and
#P \ 0.05 compared to NA-treated group, ANOVA followed by the
Newman–Keuls post test
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structures are activated after administration of NA into the
LSA. All these structures are able to cause vasopressin
release to periphery after stimulation (Busnardo et al.
2009b; Crestani et al. 2007; Fernandes et al. 2003; Fort-
aleza et al. 2011; Pelosi and Correa 2005). In contrast, no
changes in the pattern of c-Fos expression were found in
the diagonal band of Broca (DBB), cingulate cortex 1
(Cg1), and dorsolateral periaqueductal gray (dlPAG).
These results suggest areas where there was increased
expression of c-Fos protein are recruited after microinjec-
tion of NA in LSA.
NA microinjected into the BNST caused pressor and
bradycardic response dependent of vasopressin release
(Crestani et al. 2007). PVN pretreatment with the selective
non-NMDA receptor antagonist NBQX significantly
reduced these cardiovascular responses, suggesting that
glutamate-mediated neurotransmission through non-
NMDA glutamate receptors in the PVN mediates these
responses (Crestani et al. 2009b). Moreover, NA
microinjection into the dPAG (Pelosi and Correa 2005),
PL (Fernandes et al. 2003) and MeA (Fortaleza et al.
2011) also evoked pressor and bradycardiac responses that
depend on vasopressin release. The nonselective synaptic
blocker cobalt chloride injected into the PVN blocked the
cardiovascular responses caused by NA microinjected into
the dPAG (Pelosi et al. 2009) and PL (Fernandes et al.
2007) indicating that synapses in PVN mediate the vaso-
pressin-induced pressor response caused by NA
microinjection.
Glutamate microinjected into the DBB evoked pressor
and bradycardic responses that also is mediated by vaso-
pressin release into the circulation, similar to the effects
observed after NA microinjection into the dPAG (Pelosi
and Correa 2005), LSA (Scopinho et al. 2006), PL (Fer-
nandes et al. 2003), BNST (Crestani et al. 2007), SON
(Busnardo et al. 2009a), or MeA (Fortaleza et al. 2011).
The DBB plays an important role in cardiovascular mod-
ulation, and it is connected to the brain nuclei involved in
Fig. 4 Photomicrographs showing c-Fos immunohistochemistry
(arrowhead) in the medial amygdaloid nucleus (MeA), paraventric-
ular nucleus of hypothalamus (PVN), prelimbic cortex (PL), and
dPAG (dorsal periaqueductal gray), of rats that received the following
treatments into the LSA: two microinjections of aCSF (Veh ? Veh),
aCSF and noradrenaline (Veh ? NA), WB4101 and aCSF
(WB ? Veh), and WB4101 and noradrenaline (WB ? NA). Scale
bar 150 lm
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neurovegetative regulation (Cullinan and Zaborszky 1991;
Gaykema et al. 1990).
Since the LSA did not present direct connections with
the magnocellular nuclei of PVN and SON (Tavares et al.
2005), and activation of this region releases vasopressin
through the PVN but not the SON (Scopinho et al. 2008),
the structures mentioned above could be potential relays
between the LSA and the PVN. Neuroanatomical studies
using neuronal tracers show that the LSA is densely
interconnected with the amygdala (Sheehan et al. 2004;
Volz et al. 1990), PL and IL cortices (Vertes 2004) and
BNST (Risold and Swanson 1997).
On the other hand, although the LSA also presents
connections with the DBB (Tavares et al. 2005) and Cg1
cortex (Vertes 2004), we did not observ changes in the
pattern of c-Fos expression in these structures. Also,
despite no direct connections with LSA has been described
for the dPAG, only in the dorsomedial subdivision of
dPAG (dmPAG) presents increased c-Fos expression after
NA injection into the LSA, suggesting that the dmPAG but
not dorsolateral subdivions of dPAG (dlPAG) is activated
under this situation.
Varicose fibers were observed in the DBB after micro-
injection of the neurotracer BDA into the dPAG, indicating
the existence of a direct neural connection between these
two regions. Moreover, BDA microinjected into the DBB
showed the existence of direct efferent connections from
the DBB to the magnocellular portion in the PVN (Tavares
et al. 2005). DBB pretreatment with cobalt chloride (cal-
cium channel blocking agent) significantly reduced the
cardiovascular response to NA microinjection into the
dPAG (Pelosi et al. 2009). Because cobalt chloride is a
nonspecific blocker of synaptic transmission, it is sug-
gested that the response to NA microinjection into the
dPAG is mediated by synaptic neurotransmission within
the DBB and is not related to fibers of passage. However,
cobalt injection into DBB did not completely block the
dPAG-evoked cardiovascular effects. One possible expla-
nation could be the involvement of the contralateral side of
the DBB in the cardiovascular response to NA injection
into the dPAG. Another possibility could be an additional
involvement of dPAG projections to other nuclei than the
DBB.
The bradycardiac response was blocked by systemic
administration of pentolinium (ganglion blocker), without
affecting the pressor response to NA injected into the LSA.
This suggests that the bradycardia induced by the latter
treatment depends on a vagal baroreflex response conse-
quent to MAP increase (Scopinho et al. 2006). In addition,
LSA modulates baroreflex responses as well as all struc-
tures mentioned above (Crestani et al. 2006, 2008, 2010;
Pelosi et al. 2007; Quagliotto et al. 2008; Resstel et al.
2004; Scopinho et al. 2007). Since activation of the
baroreflex is able to activate the structures investigated in
this study, the present results could be reflecting a non-
specific response to changes in blood pressure. To discard
this possibility, we pretreated animals with a systemic (i.v.)
injection of the selective V1-vasopressin receptor antago-
nist dTyr(CH2)5(Me)AVP. As previously described, the
antagonist blocked the pressor and bradycardiac responses
caused by NA microinjection into the LSA (Scopinho et al.
2006), but did not affect the increase in c-Fos expression in
BNST, dmPAG, PL, IL, MeA, and PVN. We have also
reported previously that the alpha1- adrenoceptor antago-
nist WB4101 blocks pressor and bradycardic responses
evoked by NA into the LSA (Scopinho et al. 2006). The
present study confirmed these results and showed that this
treatment also attenuated the FLI increase in the BNST,
dmPAG, PL, IL, MeA, and PVN. Taken together, these
results suggest that the activation of alpha-1 adrenoceptors
in the LSA can increase neuronal activation of the afore-
mentioned regions.
The LSA is a limbic structure involved in motivational,
behavioral, and autonomic processes (Alheid and Heimer
1988; Reis et al. 2010; Sheehan et al. 2004) as well as in
cardiovascular control (Correa and Polon 1978; Gelsema
and Calaresu 1987; Scopinho et al. 2006, 2007). Norad-
renergic nerve terminals have been identified throughout
the LSA (Antonopoulos et al. 2004; Lindvall and Stenevi
1978; Risold and Swanson 1997) providing a neuroana-
tomic substrate for a septal noradrenergic influence. We
have previously demonstrated that pressor and bradycardic
responses evoked by NA injection in the LSA are due to
local a1-adrenoceptors activation and are mediated by
vasopressin release into the circulation, suggesting that
LSA noradrenergic mechanisms play a role in prosence-
phalic limbic system and vasopressin release integration.
The neurohypophyseal hormone arginine vasopressin
(AVP) is involved in several physiological regulatory
processes that occur via stimulation of specific V1a, V1b,
and V2 receptors (Thibonnier et al. 2002). The role of AVP
has been well characterized in the regulation of blood
pressure in pathophysiological conditions such as severe
hypovolemia and hypotension episodes (Laszlo et al.
1991). However, its contribution to blood pressure
homeostasis in normal physiological situations is poorly
known (Jackson et al. 1996). Vasopressin is synthesized by
magnocellular cells within the supraotic (SON) and PVN
nuclei of the hypothalamus and released into circulation by
the neurohypophysis. This hormone is a potent stimulator
of vascular smooth muscle contraction in vitro, and V1a
receptors mediate its vasoconstrictor effect (Jackson et al.
1996). Vasopressin was reported to be released in greater
proportion following several kinds of stress, such as hem-
orrhage, isotonic hypovolemia, and restraint (Kasting
1988).
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Microdialysis studies show that stressors such as
immobilization increases NA release in a number of limbic
forebrain regions, which thought to be involved in a variety
of behavioral, cognitive, affective, autonomic, and neuro-
endocrine responses to stress, including the MeA, BNST,
PL and IL cortex, and LS (Cecchi et al. 2002a, b; Garcia
et al. 2003; Ma and Morilak 2005; Pardon et al. 2002).
Also, the LSA and the structures that showed increased
expression of c-Fos after intra-LSA microinjection of NA
have been implicated in the mediation of the cardiovascular
responses observed during aversive situations (Busnardo
et al. 2010; Crestani et al. 2009a; Fortaleza et al. 2009;
Kubo et al. 2002; Leman et al. 2003; Resstel et al. 2006).
c-Fos expression occurs in neurons in response to their
activation by excitatory synaptic inputs as well as other
stimuli (Dragunow and Faull 1989; Morgan and Curran
1991). The aim of this study was to investigate: the areas
which will be activated from the microinjection of nor-
adrenaline in the LSA and so in the future and perform
functional experiments with the administration of inhibi-
tors or antagonists of synaptic neurotransmission, and thus
establish a relationship between the areas in a common
pathway. The connectivity of these structures is not pre-
sented by our results. We cannot know if these areas have
direct or indirect connections among themselves. Only
when used in combination with retrograde tracing and/or
immunohistochemical identification of neurotransmitters,
c-fos expression method can be used to define the con-
nections and transmitter properties of central neurons
activated by specific stimuli.
Conclusion
Considering that MeA, BNST, PL, and IL cortex, dmPAG
and PVN are activated by LSA stimulus with noradrena-
line, and these areas are able to evoke cardiovascular
responses depending on vasopressin release, our results
suggest that these structures constitute a cardiovascular
pathway involved with the vasopressin releases.
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